
Sanofi's expenditure on research and development from 2008 to 2022 (in million euros)
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$149 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Sanofi
Global positioning
6
- Premium Statistic Pharmaceutical market: worldwide revenue 2001-2022
- Premium Statistic Top 50 pharmaceutical companies - Rx sales and R&D spending 2022
- Premium Statistic Total global prescription drug sales of top 10 companies 2026 projection
- Premium Statistic Leading pharmaceutical companies by global vaccine revenue 2021
- Basic Statistic Projected top pharmaceutical companies based on sales 2023
- Basic Statistic Projected top pharmaceutical companies based on new sales 2023
Company key figures
5
Business distribution
5
- Premium Statistic Sanofi revenue by region 2022
- Premium Statistic Sanofi - revenue by segment 2014-2022
- Premium Statistic Sanofi pharmaceutical segment revenues by product group 2022
- Premium Statistic Sanofi: human vaccine revenues 2017-2022
- Premium Statistic Sanofi top pharmaceutical products 2021-2022
Competitors
5
COVID-19
5
- Basic Statistic COVID-19 vaccine dose numbers by top manufacturer 2021
- Basic Statistic Number of COVID-19 vaccine doses ordered by the United Kingdom 2021
- Premium Statistic Select COVID-19 vaccine pricing and funding as of August 2020
- Basic Statistic Comparison of select COVID-19 vaccines 2022, by efficacy
- Premium Statistic BARDA funding for the development of COVID-19 vaccines in the U.S. 2021
Further related statistics
20
- Basic earnings per share of Sanofi 2009-2022
- Sanofi - revenue of animal health segment 2012-2016
- Employees in Sanofi Aventis SA Spain 2010-2021
- Sanofi Aventis SA sales value 2012-2020
- Cash dividend per share of Sanofi 2009-2019
- Average number of outstanding shares of Sanofi 2009-2022
- Roche Group's number of employees 2007-2022
- Merck & Co cash dividends declared 2006-2022
- YTD stock performance of biopharma companies working on COVID March 2020
- Employees in Pfizer SL Spain 2010-2021
- Covestro SL number of employees in Spain 2011-2021
- Bristol-Myers Squibb's total assets 2015-2022
- Bristol-Myers Squibb's revenue by region 2010-2022
- Bayer Hispania SL number of employees in Spain 2011-2021
- Bristol-Myers Squibb - revenue share of key products 2006-2020
- Total operating expenses of GW Pharmaceuticals 2017-2020
- China's Shanghai Pharmaceuticals R&D expenses 2015-2022
- Europe: human and animal blood preparations import value by country 2022
- Revenue of Grifols 2014-2022
- Industry revenue of “public relations and communication activities“ in Germany 2012-2025
Further Content: You might find this interesting as well
Statistics
- Basic earnings per share of Sanofi 2009-2022
- Sanofi - revenue of animal health segment 2012-2016
- Employees in Sanofi Aventis SA Spain 2010-2021
- Sanofi Aventis SA sales value 2012-2020
- Cash dividend per share of Sanofi 2009-2019
- Average number of outstanding shares of Sanofi 2009-2022
- Roche Group's number of employees 2007-2022
- Merck & Co cash dividends declared 2006-2022
- YTD stock performance of biopharma companies working on COVID March 2020
- Employees in Pfizer SL Spain 2010-2021
- Covestro SL number of employees in Spain 2011-2021
- Bristol-Myers Squibb's total assets 2015-2022
- Bristol-Myers Squibb's revenue by region 2010-2022
- Bayer Hispania SL number of employees in Spain 2011-2021
- Bristol-Myers Squibb - revenue share of key products 2006-2020
- Total operating expenses of GW Pharmaceuticals 2017-2020
- China's Shanghai Pharmaceuticals R&D expenses 2015-2022
- Europe: human and animal blood preparations import value by country 2022
- Revenue of Grifols 2014-2022
- Industry revenue of “public relations and communication activities“ in Germany 2012-2025
Sanofi. (February 24, 2023). Sanofi's expenditure on research and development from 2008 to 2022 (in million euros) [Graph]. In Statista. Retrieved December 08, 2023, from https://www.statista.com/statistics/279202/expenditure-on-research-and-development-of-sanofi/
Sanofi. "Sanofi's expenditure on research and development from 2008 to 2022 (in million euros)." Chart. February 24, 2023. Statista. Accessed December 08, 2023. https://www.statista.com/statistics/279202/expenditure-on-research-and-development-of-sanofi/
Sanofi. (2023). Sanofi's expenditure on research and development from 2008 to 2022 (in million euros). Statista. Statista Inc.. Accessed: December 08, 2023. https://www.statista.com/statistics/279202/expenditure-on-research-and-development-of-sanofi/
Sanofi. "Sanofi's Expenditure on Research and Development from 2008 to 2022 (in Million Euros)." Statista, Statista Inc., 24 Feb 2023, https://www.statista.com/statistics/279202/expenditure-on-research-and-development-of-sanofi/
Sanofi, Sanofi's expenditure on research and development from 2008 to 2022 (in million euros) Statista, https://www.statista.com/statistics/279202/expenditure-on-research-and-development-of-sanofi/ (last visited December 08, 2023)
Sanofi's expenditure on research and development from 2008 to 2022 (in million euros) [Graph], Sanofi, February 24, 2023. [Online]. Available: https://www.statista.com/statistics/279202/expenditure-on-research-and-development-of-sanofi/